With a need to balance scientific invention with commercial objectives, the company needed IP advisers who could both gain the confidence of its scientists and engineers and help it meet its commercial objectives.
In 2018, we preserved the European patent in a successful defence in EPO opposition proceedings filed by two generic pharmaceutical manufacturers.
We helped online voiceover marketplace, Voices.com, to secure the European trade mark VOICEBANK, following objections by the EUIPO that it lacked distinctiveness.
As part of a long-standing relationship with an Italian IP firm, we have advised one of Italy’s largest banking groups, on UK trade mark matters.
We were instructed by two global pharmaceutical companies, H. Lundbeck A/S and Takeda Pharmaceuticals, to defend an opposition filed against their patent to an antidepressant medication vortioxetine (marketed as Brintellix).
In one of the most significant patent cases of 2018/19, we fielded a 15-strong multidisciplinary team of specialist IP solicitors and patent attorneys to secure a global settlement for Alnylam Pharmaceuticals Inc.